CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 71 enrolled
Drug / intervention
carboxymethylcellulose 0.5% +glycerin 0.9% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00938704
NCT00938704Phase 4Completed
CompareCT.gov

Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

Allergan·interventional·Posted Jul 14, 2009·Updated Oct 31, 2011

In Brief

A Phase 4 clinical trial evaluating carboxymethylcellulose 0.5% +glycerin 0.9% and sodium hyaluronate 0.18% for Dry Eye Syndromes. Completed, enrolled 71 participants across 1 site.

Detailed Summary

To compare the efficacy and safety of two non-preserved artificial tears, (carboxymethylcellulose 0.5%, + glycerin 0.9% vs. sodium hyaluronate 0.18%) eye drops for the treatment of the signs and symptoms of dry eye disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 14, 2009
Enrollment StartJun 1, 2009
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 17.0 years ago

Interventions

carboxymethylcellulose 0.5% +glycerin 0.9%drug

To open, twist and pull tab to remove. Instill study medication as needed, but at least one drop 3 times a day as instructed in the protocol and then discard the container.

sodium hyaluronate 0.18%drug

To open, twist and pull tab to remove. Instill study medication as needed, but at least one drop 3 times a day as instructed in the protocol and then discard the container.